<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-145760</identifier>
<setSpec>0211-6995</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Interstitial pneumonitis associated to sirolimus administrion in a patient with renal transplantation: a clinical case</dc:title>
<dc:description xml:lang="en">Sirolimus is an immunosuppressive drug which has proved its effectivity to reduce the incidence of acute rejection in renal transplantation receptors. As this drug lacks nephrotoxic effects, its simultaneous use with other anticalcineurinic drugs allows the use of reduced doses. Thrombocytopenia and hyperlipidemia are the best known side-effects of sirolimus administration. Alterations in hepatic biochemistry results are also common. Some instances of interstitial pneumonitis associated to its use have been recently reported. In this paper we present a clinical case related to this rare but already confirmed adverse side-effect, which apart from the other more common nosologies occurring in immunosuppressed patients, should be taken into account in the differential diagnosis of interstitial pneumonitis in patients who are being administered this drug (AU)</dc:description>
<dc:creator>Toro, J</dc:creator>
<dc:creator>López, M</dc:creator>
<dc:creator>Pereira, P</dc:creator>
<dc:creator>Mateos, J</dc:creator>
<dc:creator>Gentil, MA</dc:creator>
<dc:creator>González Roncero, FM</dc:creator>
<dc:creator>Rodríguez Algarra, G</dc:creator>
<dc:creator>Martínez, M</dc:creator>
<dc:creator>Valdivia, MA</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El sirolimus es un fármaco inmunosupresor que se ha demostrado eficaz en la reducción de la incidencia de rechazo agudo en los receptores de trasplante renal. Al no tener efectos nefrotóxicos, su uso sinérgico con otros anticalcineurínicos permite potencialmente la reducción de la dosis de estos. Entre sus efectos secundarios más conocidos se encuentra la trombocitopenia y la hiperlipidemia. También es frecuente la aparición de alteraciones en la bioquímica hepática. Recientemente se ha comunicado la existencia de algunos casos de neumonitis intersticial asociada al uso de sirolimus. Presentamos un caso clínico relativo a este infrecuente pero ya constatado efecto adverso, que creemos debe ser tenido en cuenta en el diagnóstico diferencial de las neumonías intersticiales que aparezcan en los pacientes que estén en tratamiento con este fármaco, junto con las otras nosologías de más frecuente aparición en el paciente inmunodeprimido (AU)</dc:description>
<dc:source>Nefrologia;24(supl.3): 7-10, 2004. ilus</dc:source>
<dc:identifier>ibc-145760</dc:identifier>
<dc:title xml:lang="es">Neumonitis intersticial asociada al uso de sirolimus en un trasplantado renal: un caso clínico</dc:title>
<dc:subject>^d9365^s22003</dc:subject>
<dc:subject>^d33809^s22020</dc:subject>
<dc:subject>^d31333^s22036</dc:subject>
<dc:subject>^d11622^s22016</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d7344^s22020</dc:subject>
<dc:subject>^d30747^s22073</dc:subject>
<dc:subject>^d11622^s22036</dc:subject>
<dc:subject>^d30164^s22073</dc:subject>
<dc:subject>^d5801^s22073</dc:subject>
<dc:subject>^d31333^s22016</dc:subject>
<dc:subject>^d22622^s22073</dc:subject>
<dc:subject>^d32073^s22016</dc:subject>
<dc:subject>^d9365^s22073</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d29475</dc:subject>
<dc:subject>^d4419</dc:subject>
<dc:subject>^d24649^s22073</dc:subject>
<dc:subject>^d964^s22073</dc:subject>
<dc:subject>^d9327^s22036</dc:subject>
<dc:subject>^d1394^s22073</dc:subject>
<dc:subject>^d4294^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>200400</dc:date>
</metadata>
</record>
</ibecs-document>
